Laurus Labs announced a 126% rise in Q2 FY27 net profit to ₹441 crore and reported H1 revenue of ₹4,233 crore. The company also acquired a 60% stake in Galenvs Sciences to boost oligonucleotide capabilities. Mumbai: Laurus Labs Limited on Thursday, 29 October 2026, announced a net profit of ₹441 crore for the second quarter (Q2) of fiscal year 2027, a 126% increase compared to ₹195 crore in Q2 FY26.